Clinical Trials · NCT06974344
Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- King Faisal Specialist Hospital & Research Center
- Enrollment
- 80
- Start date
- Jun 2025
- Locations
- 1 site, Saudi Arabia
- Primary endpoint
- Median Comprehensive Complication Index® (CCI®)